|Articles|July 14, 2016
Merck US Job Cuts "Likely to Affect About 300 Workers"
July 14, 2016
Advertisement
As it builds news research hubs in Massachusetts and California, Merck's job cuts in New Jersey and Pennsylvania are likely to affect about 300 workers,
Although the company is not currently providing a breakdown of the changes or specific numbers of impacted employees, a Merck spokesperson told Fortune: “[W]e anticipate that less than 10 percent of discovery, pre-clinical and early development colleagues will be impacted".
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Novavax Enters $530 Million License Agreement with Pfizer for Vaccine Development
4
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
5